Clinical trial • Phase I • Oncology
KUP-101A for Advanced solid tumours | Cutaneous melanoma | Mucosal melanoma | Cutaneous squamous cell carcinoma | Merkel cell carcinoma | Basal cell carcinoma
Phase I trial of KUP-101A for Advanced solid tumours | Cutaneous melanoma | Mucosal melanoma | Cutaneous squamous cell carcinoma | Merkel cell carcinoma |…
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumours | Cutaneous melanoma | Mucosal melanoma | Cutaneous squamous cell carcinoma | Merkel cell carcinoma | Basal cell carcinoma
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 18-09-2025
- First CTIS Authorization Date
- 12-11-2025
Trial design
Phase I trial across 5 sites in Germany.
- Target Sample Size
- 21
Eligibility
Recruits 21 No vulnerable populations selected..
- Vulnerable Population
- No vulnerable populations selected.
Recruitment
- Planned Sample Size
- 21
- Recruitment Window Months
- 19
Geography
- Total Number Of Sites
- 5
- Total Number Of Participants
- 21
Germany
- Earliest CTIS Part Ii Submission Date
- 07-11-2025
- Latest Decision Or Authorization Date
- 20-04-2026
- Processing Time Days
- 164
- Number Of Sites
- 5
- Number Of Participants
- 21
Sites
- Site Name
- Fachklinik Hornheide e.V.
- Department Name
- Dermatologie
- Principal Investigator Name
- Carmen Loquai
- Principal Investigator Email
- carmen.loquai@fachklinik-hornheide.de
- Contact Person Name
- Carmen Loquai
- Contact Person Email
- carmen.loquai@fachklinik-hornheide.de
- Site Name
- Universitaetsklinikum Wuerzburg AöR
- Department Name
- Department of Dermatology
- Principal Investigator Name
- Anja Heike Gesierich
- Principal Investigator Email
- Gesierich_A@ukw.de
- Contact Person Name
- Anja Heike Gesierich
- Contact Person Email
- Gesierich_A@ukw.de
- Site Name
- LMU Klinikum Muenchen AöR
- Department Name
- Klinik und Poliklinik für Dermatologie und Allergologie
- Principal Investigator Name
- Dirk Tomsitz
- Principal Investigator Email
- dirk.tomsitz@med.uni-muenchen.de
- Contact Person Name
- Dirk Tomsitz
- Contact Person Email
- dirk.tomsitz@med.uni-muenchen.de
- Site Name
- Universitaetsklinikum Koeln AöR
- Department Name
- Klinik für Dermatologie und Venerologie
- Principal Investigator Name
- Cindy Franklin
- Principal Investigator Email
- cindy.franklin@uk-koeln.de
- Contact Person Name
- Cindy Franklin
- Contact Person Email
- cindy.franklin@uk-koeln.de
- Site Name
- St. Josef-Hospital
- Department Name
- Department of Dermatology
- Principal Investigator Name
- Eggert Stockfleth
- Principal Investigator Email
- eggert.stockfleth@klinikum-bochum.de
- Contact Person Name
- Eggert Stockfleth
- Contact Person Email
- eggert.stockfleth@klinikum-bochum.de
Sponsor
Primary sponsor
- Full Name
- Kupando GmbH
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Germany
Investigational products
- Investigational Product Name
- KUP-101A
- First In Human
- Yes
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)